z-logo
open-access-imgOpen Access
Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First Approval
Author(s) -
Lillian R. Klug,
Christopher L. Corless,
Michael C. Heinrich
Publication year - 2021
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.20.03245
Subject(s) - medicine , imatinib , clinical oncology , oncology , citation , tyrosine kinase inhibitor , imatinib mesylate , cancer , cancer research , library science , myeloid leukemia , computer science

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom